Jean-Christophe Corvol, MD, PhD
Professor of Neurology
Prof. Corvol has a training in both clinical (MD, 2003) and basic (PhD, 2005) research in the field of Neurology and Pharmacology. After a residency in Neurology in Paris, he completed a PhD on dopamine signal transduction in animal models of Parkinson’s disease and drug addiction. He had a postdoctoral position (2006-2007) in the lab of molecular neurogenetics of Jorge Oksenberg (UCSF) where he did transcriptomics experiments. In 2007, as Assistant Professor at the Department of Pharmacology at the Pitié-Salpêtrière Hospital he began to participate in clinical research. Currently, Prof. Corvol is Professor of Neurology at the Department of Neurology of the same hospital, at the head of the Clinical Research Center for Neurosciences, co-chair of the French clinical research network for Parkinson’s disease and movement disorders (NS-Park), and PI in the neurogenetic research laboratory at the ICM (Alexis Brice). His fields of interest are pharmacology, genetics and pharmacogenetics of Parkinson’s disease. He is a member of the French Society for Neurology, the French Society for Pharmacology, MDS, the Scientific Committee for Neurosciences of INSERM, and a new member of the editorial board of Movement Disorders. He is author of 84 papers referenced in PubMed.
Susanne A. Schneider, MD
Consultant Neurologist, Department of Neurology
University Hospital Kiel
Dr. Schneider gained her neurological training at the UCL Institute of Neurology (2005-2008) and the University of Lübeck, Germany (2008-2012), and completed a PhD program in the field of Neuroscience in London and Habilitation in Germany. She has published in a number of high impact journals, and has been awarded several internationally prestigious prizes including the William Koller Memorial Fund Award from the International Movement Disorder Society, the Jon Stolk Award in Movement Disorders for Young Investigators from the American Academy of Neurology and the David Marsden Award from the European Dystonia Society, as well as other prizes and awards. She has lectured at national and international scientific meetings and Movement Disorders training programs and is an Editorial board member of the Movement Disorders Journal.
Matej Skorvanek, MD, PhD
Clinician, Department of Neurology
Safarik University and University Hospital of L. Pasteur
Kosice, Slovak Republic
Dr. Skorvanek graduated the Medical Faculty and later received specialization in Neurology at the Safarik University in Kosice, Slovakia. He finished his PhD at the University of Groningen, Netherlands. During his training in the field of Movement Disorders he attended study stays at Charles University, Prague, Czech Republic and at UCL, Queens Square, London, UK. Later he initiated and now is in charge of the DBS program for Movement Disorders and pump therapies for advanced Parkinson’s disease in the University Hospital of L. Pasteur in Kosice, Slovakia. He is actively involved within the MDS Task Force on the Development of the MDS-UPDRS and the EU COST action “European network for the study of dystonia syndromes”. His main research interests include non-motor symptoms and quality of life issues in Parkinson’s disease, premotor biomarkers of Parkinson’s disease with focus on tissue biomarkers and clinical and genetic research of dystonia syndromes.
Maria Stamelou, MD, PhD
Consultant Neurologist, Second Department of Neurology
University of Athens
Dr. Stamelou completed her medical studies in Thessaloniki, Greece and then joined the Department of Neurology in Philipps University Marburg in 2005. She started, at the same time, clinical research mainly on PSP, and established a specialized out-patient clinic for atypical parkinsonian conditions, which counted more than 100 patients with PSP, after two years. After completing neurology training, she joined UCL, Queen Square, with Prof Kailash Bhatia.
Dr. Stamelou has been invited the last four consecutive years to give a talk in the MDS International Congress and also in MDS Summer School. She is a member of the MDS PSP-study group, the MDS study group for developing a CBD staging system, and the MDS tremor task-force for the classification of tremor. She has been assistant editor in Movement Disorders Journal since April 2013. In October 2014, she organized the first MDS teaching course in Athens, “Genetics of Parkinson’s disease and parkinsonian syndromes in clinical practice”. This was the first MDS course with this topic.